摘要
液体活检技术的类别及性能有了更加广阔的发展。大量研究逐步展现出液体活检生物标志物具有改变肿瘤诊疗模式的巨大潜力。液体活检技术展现出了前所未有的机遇与挑战。当下面临的关键问题是如何将实验室中的技术转化为具有明确临床应用价值的分子诊断产品。
Researchers have made remarkable progress in developing more advanced assays of liquid biopsy in recent year.More studies have demonstrated the tremendous potential of liquid biopsy biomarkers in changing cancer diagnosis and treatment scenarios.Facing unprecedented opportunities and challenges,scientists must achieve a vital milestone by transforming liquid biopsy from research experimental methods into a molecular diagnostic product with clear clinical utilization.
作者
郭玮
Guo Wei(Department of Laboratory Medicine,Zhongshan Hospital,Fudan University.Shanghai 200032,China)
出处
《中华检验医学杂志》
CAS
CSCD
北大核心
2021年第3期179-180,共2页
Chinese Journal of Laboratory Medicine